Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study.
Klevebro F, Nilsson K, Lindblad M, Ekman S, Johansson J, Lundell L, Ndegwa N, Hedberg J, Nilsson M. Klevebro F, et al. Among authors: ekman s. Dis Esophagus. 2020 May 15;33(5):doz078. doi: 10.1093/dote/doz078. Dis Esophagus. 2020. PMID: 31676895 Free PMC article. Clinical Trial.
Esophageal cancer: current and emerging therapy modalities.
Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, Bergqvist M. Ekman S, et al. Expert Rev Anticancer Ther. 2008 Sep;8(9):1433-48. doi: 10.1586/14737140.8.9.1433. Expert Rev Anticancer Ther. 2008. PMID: 18759695 Review.
Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
Holgersson G, Bergström S, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Birath E, Ekman S, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R. Holgersson G, et al. Among authors: ekman s. Eur J Cancer. 2011 Nov;47(16):2415-21. doi: 10.1016/j.ejca.2011.06.011. Epub 2011 Jul 2. Eur J Cancer. 2011. PMID: 21726999
The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy.
Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Brodin O, Holgersson M, Lundström KL, Janson C, Ekberg L, Mörth C, Blystad T, Ewers SB, Löden B, Bergqvist M. Holgersson G, et al. Among authors: ekman s. Anticancer Res. 2012 Apr;32(4):1339-46. Anticancer Res. 2012. PMID: 22493368
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial.
Hallqvist A, Bergström S, Björkestrand H, Svärd AM, Ekman S, Lundin E, Holmberg E, Johansson M, Friesland S, Nyman J. Hallqvist A, et al. Among authors: ekman s. Lung Cancer. 2018 Aug;122:180-186. doi: 10.1016/j.lungcan.2018.06.020. Epub 2018 Jun 18. Lung Cancer. 2018. PMID: 30032828 Clinical Trial.
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage.
Franzén B, Viktorsson K, Kamali C, Darai-Ramqvist E, Grozman V, Arapi V, Hååg P, Kaminskyy VO, Hydbring P, Kanter L, Nyrén S, Ekman S, De Petris L, Lewensohn R. Franzén B, et al. Among authors: ekman s. Mol Oncol. 2021 Nov;15(11):2941-2957. doi: 10.1002/1878-0261.12952. Epub 2021 May 1. Mol Oncol. 2021. PMID: 33768639 Free PMC article.
334 results